DAT SPECT and Procedural Motor Skills in Parkinson's Disease
NCT ID: NCT03076307
Last Updated: 2017-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2016-10-18
2017-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With the present study, the investigators expect to enroll patients with early PD for whom a 123I-FP-CIT SPECT has been previously performed in the center. Subjects will perform a specific motor task based on mirror-drawing of star-shaped figures. This will be done by inverting the direction of horizontal/vertical computer mouse movements on the screen. Speed and error rates will be assessed for patients as well as healthy control subjects. Correlation with striatal SPECT uptake, especially caudate nucleus uptake, will be analyzed for PD patients. In addition, resting-state EEG will be performed for all subjects. General medication and dopaminergic drugs in particular, whenever used, will not be discontinued. For all subjects enrolled in the study, cognitive and neurological examination will be performed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-motor Symptoms and Brain Dopamine Transporter Binding
NCT02650843
The Learning Effects of Attentional Strategy on Dual-task Walking in Patients With Parkinson's Disease: Behavioral Performance and Neural Plasticity
NCT03895125
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282
Movement Error-processes and Sensorimotor Adaptation in Parkinsonian Patient
NCT03371407
Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training
NCT05696197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
Procedural Motor Skills with mirror-drawing of figures
Evaluation of error rate and speed for completion of a procedural motor task
Control group
Procedural Motor Skills with mirror-drawing of figures
Evaluation of error rate and speed for completion of a procedural motor task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Procedural Motor Skills with mirror-drawing of figures
Evaluation of error rate and speed for completion of a procedural motor task
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of PD with onset \<2 years from enrollment
* Available DAT SPECT performed in Geneva University Hospitals \<6 months before inclusion
Age- and sex-matched control patients
* Age \> 18 year-old
* No known neurological condition interfering with motor and cognitive abilities
* No medication interfering with central nervous system (including antidepressants, antipsychotics, hypnotics)
Exclusion Criteria
* Cognitive decline (Mini-Mental Score ≤ 22/30)
* Debilitating tremor (Movement Disorders Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III - rest, postural and action tremor ≥2/4)
* Significant akinesia (MDS-UPDRS III hand brady-akinesia score ≥2/4)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicolas Nicastro
Dr. Med. Nicolas NICASTRO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Neurorehabilitation, Geneva University Hospitals
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCER 2016-01469
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.